XClinical’s Key Executives to Present at CDISC in Copenhagen
XClinical’s CEO, Dr. Philippe Verplancke, has been selected to speak at the CDISC European Interchange in Copenhagen in April 2008 where he will discuss the challenges of combining user-friendliness and CDISC data standards in an EDC system. XClinical is furthermore contributing to the CDISC End-to-End Workshop (“CORE”). Dr. Verplancke has recently been invited to perform the official ODM/define.xml trainings and will be an official guest speaker at CDISC road shows and user-group meetings in 2008.
(firmenpresse) - XCLINICAL GMBH, Munich, Germany – April 9, 2008 – XClinical, a European vendor of innovative software products for eClinical trials and well known for MARVIN, one of the first CDISC certified EDC software solutions, today announced its comprehensive participation at the CDISC European Interchange to be held on April 21-25, 2008, at The Marriott Hotel in Copenhagen, Denmark.
XClinical’s CEO, Dr. Philippe Verplancke, has been invited to present a lecture focused on "Experience with SDTM value level metadata in investigator centered EDC and CDASH". Dr. Verplancke will not only share valuable insights with respect to the progress of CDISC data standards, but will further answer the question of how clinical data standardization can be made compatible with an EDC vendors main goal of providing a user-friendly EDC system for clinical trials.
In addition, XClinical will participate in the CDISC End-to-End workshop “CORE” (CDISC Operational Roadmap Environment). The workshop is an important additional project to further drive the adoption of common standards across the industry worldwide by showing the platform and system independency of the CDISC standard models. Dr. Lindenau, XClinical’s head of business development, will
contribute to the upcoming event in Copenhagen: “The industry has already made moves towards end-to-end processing with the CDISC data model for common standards in clinical trials, hence, as an EDC software provider, XClinical has a strong commitment to this concept”.
To further advance the mission of the consortium with respect to the development and dissemination of standard data models throughout the industry, CDISC has recently developed specialized training programs. The goals of these programs are to provide training and education on the theory and practice of using the CDISC standards and to provide the tools and information needed to implement these within organizations. As a recognized expert in CDISC standards, Dr. Verplancke will host 7 official training sessions, organized by CDISC around the globe in 2008, dealing with the advantages of XML use in data acquisition, data exchange, and data transfer. “Our goal is the fast accreditation and use of these standards throughout the industry, and the adoption of them by regulatory authorities”, said Dr. Verplancke, who replaces the former official trainer Dave Iberson-Hurst who has been selected as Vice President for CDISC, recently.
XClinical’s executives can be reached personally during the event at Booth No. 9.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM). To date, MARVIN has been used to collect and process data of more than 50,000 patients in 50+ studies.
XClinical GmbH
Siegfriedstrasse 8
80803 Munich
Germany
Email: press(at)xclinical.com
Datum: 09.04.2008 - 07:51 Uhr
Sprache: Deutsch
News-ID 1000457
Anzahl Zeichen: 0
contact information:
Contact person: Simone A. Hoerrlein
Town:
Munich
Phone:
Kategorie:
Computer & Software
Anmerkungen:
Diese Pressemitteilung wurde bisher 573 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"XClinical’s Key Executives to Present at CDISC in Copenhagen
"
steht unter der journalistisch-redaktionellen Verantwortung von
XClinical GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
